{"version":"1.0","provider_name":"Federassantas","provider_url":"https:\/\/www.federassantas.org.br\/novosite","title":"Anvisa aprova novo medicamento para preven\u00e7\u00e3o do AVC - Federassantas","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"iecYskmPc0\"><a href=\"https:\/\/www.federassantas.org.br\/novosite\/anvisa-aprova-novo-medicamento-para-prevencao-do-avc\/\">Anvisa aprova novo medicamento para preven\u00e7\u00e3o do AVC<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.federassantas.org.br\/novosite\/anvisa-aprova-novo-medicamento-para-prevencao-do-avc\/embed\/#?secret=iecYskmPc0\" width=\"600\" height=\"338\" title=\"&#8220;Anvisa aprova novo medicamento para preven\u00e7\u00e3o do AVC&#8221; &#8212; Federassantas\" data-secret=\"iecYskmPc0\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.federassantas.org.br\/novosite\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":null,"thumbnail_width":null,"thumbnail_height":null,"description":"A Anvisa (Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria) aprovou nesta ter\u00e7a-feira (6) novo medicamento que evita a coagula\u00e7\u00e3o do sangue e, com isso, previne condi\u00e7\u00f5es como o AVC (Acidente Vascular Cerebral). A droga, chamada de Lixiana (edoxabana), tamb\u00e9m previne trombose venosa e embolia pulmonar. Essas condi\u00e7\u00f5es t\u00eam em comum o fato de que podem ser causadas [&hellip;]"}